Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases-Reference-Cited by-同舟云学术

Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases

Published:2018-11-21 Issue:3 Volume:74 Page:761-767
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Kaindl Thomas¹,Andes David²,Engelhardt Marc¹,Saulay Mikael³,Larger Patrice¹,Groll Andreas H⁴

Affiliation:

1. Basilea Pharmaceutica International Ltd, Basel, Switzerland

2. Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA

3. ICON plc, Allschwil, Switzerland

4. Department of Paediatric Haematology/Oncology, University Children’s Hospital Münster, Münster, Germany

Funder

Basilea Pharmaceutica International Ltd

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/3/761/27785412/dky463.pdf

Reference30 articles.

1. Recent developments in the management of invasive fungal infections in patients with oncohematological diseases;Ruhnke;Ther Adv Hematol,2016

2. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America;Patterson;Clin Infect Dis,2016

3. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients;Tissot;Haematologica,2016

4. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology;Ashbee;J Antimicrob Chemother,2014

5. Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014;Chau;Intern Med J,2014

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing;Journal of Antimicrobial Chemotherapy;2024-08-01

2. Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety;Antibiotics;2024-07-29

3. Effectiveness of isavuconazole in invasive cerebral aspergillosis during hematopoietic stem cell transplantation in a pediatric patient with myelodysplastic syndrome: A case report;Journal of Infection and Chemotherapy;2024-07

4. Successful Isavuconazole Treatment for Pulmonary Mucormycosis in a Patient Intolerant to Liposomal Amphotericin B with Pharmacokinetic Insights: A Case Report;Chemotherapy;2024-06-15

5. Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety;2024-03-15